Angiomics® — cardiac CT

The essential solution for chest-pain triage.

Angiomics brings advanced AI to coronary stenosis detection, offering rapid and clinically relevant insights for patients with acute chest pain. Validated with emergency-room data.

Regulatory clearance obtained in South Korea (MFDS). Angiomics ER received Class 3 digital medical device approval in 2026; overseas approvals are being pursued in the U.S., Japan and Europe.

Angiomics
Triage

Effortless triage for acute chest pain

Deep-learning algorithms automatically detect regions with 50% or greater stenosis on coronary CT angiography, so emergency teams can prioritize the patients who need intervention first.

Speed

Analysis in 5 to 10 minutes

Results are returned within minutes of the scan, shortening time to decision in the emergency department. The final reading always remains with the physician.

Clarity

Simple analysis, clear insights

Obtain the critical information needed for clinical decision-making with one click: stenosis location, severity and a clear summary for the care team.

Evidence

Validated in a confirmatory clinical trial

Clinical performance of Angiomics ER was verified in a confirmatory clinical trial at Severance Hospital, and a multi-center deep-learning study on obstructive CAD detection in acute chest pain was published in 2025.

Some features are for research use only and may not be available for clinical use in certain regions.

Shorten the path from chest pain to decision.

Contact us to discuss emergency-department deployment, clinical studies or distribution in your market.

⚡ Made with pagesss